James Howard-Tripp
-
Jack Lifton with StageZero’s James Howard-Tripp on the advantages of non-invasive cancer diagnostic testing
In a recent InvestorIntel interview, Jack Lifton speaks with James Howard-Tripp, Chairman and CEO of StageZero Life Sciences…
-
eResearch’s Chris Thompson with James Howard-Tripp on StageZero’s COVID-19 testing revenue
In a recent InvestorIntel interview, Chris Thompson speaks with James Howard-Tripp, Chairman and CEO of StageZero Life Sciences…
-
James Howard-Tripp on StageZero’s Q1 Results, Aristotle as part of the AVRT Program and the Rexall Partnership for COVID-19 Saliva Tests
In a recent InvestorIntel interview, Tracy Weslosky spoke with James Howard-Tripp, Chairman and CEO of StageZero Life Sciences Ltd. (TSX:…
-
StageZero Life Sciences James Howard-Tripp on the recent LOI to Acquire Health Clinics Limited
In a recent InvestorIntel interview, Tracy Weslosky spoke with James Howard-Tripp, Chairman and CEO of StageZero Life Sciences…
-
StageZero on revenues being generated via testing operations, partners and a status report on the Aristotle test
In a recent InvestorIntel interview, Tracy Weslosky speaks with James Howard-Tripp, Chairman and CEO of StageZero Life Sciences…
-
Kozak on StageZero: Come for COVID, stay for the cancer testing
“15 years of work”, is how StageZero Life Sciences Ltd. (TSX: SZLS) Chairman and CEO James Howard-Tripp described…
